Sign in

CIK 0001759425

  • Large accelerated filer

Mirum Pharmaceuticals, Inc.

Sign in to watch
Ticker
MIRM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831281555
Phone
+1 650-667-4085
Business address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
  1. 4 Option exercise CHIEF FINANCIAL OFFICER acquired 18,334 shares (option exercise)
  2. 4 Open-market buy Director bought 230 shares at $41.58 ($9,563)
  3. 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 34,013 shares (option exercise)
  4. 4 Open-market sale SVP, GLOBAL CONTROLLER sold 375 shares at $34.00 ($12,750)
  5. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 30,559 shares at $34.00 ($1,039,006)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale Director sold 5,000 shares at $25.68 ($128,400)
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 470 shares (grant or award)
  15. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 817 shares (grant or award)
  16. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 94 shares (grant or award)
  17. 4 Open-market buy CHIEF FINANCIAL OFFICER bought 2,000 shares at $24.80 ($49,600)
  18. 4 Open-market sale PRESIDENT AND COO sold 4,303 shares at $25.80 ($111,017)
  19. 4 Open-market sale PRESIDENT AND COO sold 1,379 shares at $20.62 ($28,438)
  20. 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 1,379 shares at $20.62 ($28,438)

Page 7 of 18 · 356 filings